natgillin/translations-raw huggingface dataset:
ADVICE ON CORRECT ADMINISTRATION Mixing instructions: mg Econor 10% premix/kg feed = Dosage required (mg/kg) x 10 x bodyweight (kg)/Daily feed intake (kg)
NASVET O PRAVILNI UPORABI ZDRAVILA Navodila za pripravo mešanice: mg Econor 10 % predmešanica/kg krme = priporočen odmerek (mg/kg) x 10 x telesna masa (kg)/količino dnevnega vnosa krme (kg)
ADVICE ON CORRECT ADMINISTRATION Mixing instructions: mg Econor 50% premix/kg feed = Dosage required (mg/kg) x 2 x bodyweight (kg)/Daily feed intake (kg)
NASVET O PRAVILNI UPORABI ZDRAVILA Navodila za pripravo mešanice: mg Econor 50 % predmešanica/kg krme = priporočen odmerek (mg/kg) x 2 x telesna masa (kg)/količino dnevnega vnosa krme (kg)
Advice on escalating Lojuxta dose gradually to improve tolerability of the medicine;
Nasvet glede postopnega večanja odmerka zdravila Lojuxta, da se izboljša prenašanje zdravila;
Advice on missed doses
Navodilo v primeru izpuščenega odmerka
Advice on suitable tests
nasvete za ustrezne teste,
Advice on suitable tests
o nasvete o ustreznih testih
Advice on the need and duration of barrier contraception
Svetovanje o potrebi po pregradni kontracepciji in trajanju njene uporabe
Advice on the need to continue on a low-fat diet and avoid drinking alcohol
Svetovanje o potrebi po nadaljevanju diete z majhnim vnosom maščob in potrebi po izogibanju alkoholu
Advice that necitumumab should not be administered to patients with multiple risk factors for thromboembolic events unless the benefits outweigh the risks to the patient
Priporočilo, da se necitumumaba ne sme dati bolnikom z več dejavniki tveganja za trombembolične dogodke, razen če koristi odtehtajo tveganja za bolnika
Advice that patients and physicians should be aware of signs and symptoms of thromboembolism.
Svetujte bolnikom in zdravnikom, naj bodo pozorni na znake in simptome trombembolije.
Advice to doctors:
Nasvet za zdravnike:
Advice to exercise caution if Lojuxta is used with other hepatotoxic drugs and to consider more frequent monitoring of liver-related tests;
Nasvet o previdnosti, če se zdravilo Lojuxta uporablja z drugimi hepatotoksičnimi zdravili, in o razmisleku o pogostejšem spremljanju rezultatov jetrnih preiskav;
Advice to patients about the risk of concomitant alcohol intake;
Nasvet za bolnike o tveganju sočasnega uživanja alkohola;
Advice to patients about:
Nasvet bolnikom glede:
Advice to physicians: Sedadex is an α2-adrenoreceptor agonist, symptoms after absorption may involve clinical effects including dose-dependent sedation, respiratory depression, bradycardia, hypotension, a dry mouth, and hyperglycaemia.
Nasvet zdravnikom: zdravilo Sedadex je agonist α2-adrenoreceptorjev, simptomi po absorpciji lahko vključujejo klinične učinke, vključno s sedacijo odvisno od odmerka, dihalnim zastojem, bradikardijo, hipotenzijo, suhimi usti in hiperglikemijo.
Advise female patients of reproductive potential to use highly effective contraception during treatment with trametinib and for 4 months after treatment.
Ženskam v rodni dobi je potrebno svetovati, da morajo med zdravljenjem in še 4 mesece po prenehanju zdravljenja s trametinibom uporabljati učinkovito kontracepcijo.
Advise patients to place used dressings and cleaning materials in a sealed plastic bag as they may be potentially contaminated, and to dispose of the bag in household waste.
Bolnikom naročite, naj uporabljene povoje in materiale za čiščenje dajo v zapečateno plastično vrečko, ker so lahko kontaminirani, in vrečko vržejo v gospodinjske odpadke.
Advise your doctor if you are a carrier of the hepatitis B virus (HBV), if you have active HBV or if you think you might be at risk of contracting HBV.
Zdravniku morate povedati, če ste nosilec virusa hepatitisa B (HBV), če imate aktiven HBV ali če mislite, da bi se lahko nalezli HBV.
Advise your doctor if you have a history of recurrent infections or other conditions that increase the risk of infections.
Zdravniku povejte, če ste imeli v preteklosti ponavljajoče se okužbe ali druge bolezni, ki zvečujejo tveganje za okužbe.
Advise your doctor if you reside or travel in regions where fungal infections such as histoplasmosis, coccidioidomycosis or blastomycosis are endemic.
Zdravniku morate povedati, če živite na območju ali potujete v predele, kjer so endemične glivične okužbe, npr. histoplazmoza, kokcidioidomikoza ali blastomikoza.
Advise your doctor if your child has a history of recurrent infections or other conditions that increase the risk of infections.
Zdravniku povejte, če je vaš otrok imel v preteklosti ponavljajoče se okužbe ali druge bolezni, ki zvečujejo tveganje za okužbe.
Advise your doctor if your child is a carrier of the hepatitis B virus (HBV), if he/she has active HBV or if you think he/she might be at risk of contracting HBV.
Zdravniku morate povedati, če je vaš otrok nosilec virusa hepatitisa B (HBV), če ima aktiven HBV ali če mislite, da bi se lahko nalezel HBV.
Advise your doctor if your child resides or travels in regions where fungal infections such as histoplasmosis, coccidioidomycosis or blastomycosis are endemic.
Zdravniku morate povedati, če vaš otrok živi na območju ali potujete v predele, kjer so endemične glivične okužbe, npr. histoplazmoza, kokcidioidomikoza ali blastomikoza.
Advises HCPs on the risks of phototoxicity, skin SCC and liver toxicity associated with voriconazole use.
vetuje zdravstvenim delavcem o tveganjih fototoksičnosti, ploščatoceličnega karcinoma kože in hepatotoksičnosti, povezanih z uporabo vorikonazola;
Advocate 100 mg + 25 mg spot-on solution for medium dogs Imidacloprid, moxidectin
Advocate 100 mg + 25 mg, kožni nanos, raztopina za srednje velike pse Imidakloprid, moksidektin
Advocate 250 mg + 62.5 mg spot-on solution for large dogs Imidacloprid, moxidectin
Advocate 250 mg + 62,5 mg, kožni nanos, raztopina za velike pse Imidakloprid, moksidektin
Advocate 40 mg + 10 mg spot-on solution for small dogs Imidacloprid, moxidectin
Advocate 40 mg + 10 mg, kožni nanos, raztopina za male pse Imidakloprid, moksidektin
Advocate 40 mg + 4 mg spot-on solution for small cats and ferrets Advocate 80 mg + 8 mg spot-on solution for large cats
Advocate 40 mg + 4mg, kožni nanos, raztopina za male mačke in bele dihurje Advocate 80 mg + 8 mg, kožni nanos, raztopina za velike mačke
Advocate 40 mg + 4 mg spot-on solution for small cats and ferrets Advocate 80 mg + 8 mg spot-on solution for large cats Imidacloprid, moxidectin
Advocate 40 mg + 4 mg, kožni nanos, raztopina za male mačke in bele dihurje Advocate 80 mg + 8 mg, kožni nanos, raztopina za velike mačke Imidakloprid, moksidektin
Advocate 40 mg + 4 mg spot-on solution for small cats and ferrets Imidacloprid, moxidectin
Advocate 40 mg + 4 mg, kožni nanos, raztopina za male mačke in bele dihurje
Advocate 80 mg + 8 mg spot-on solution for large cats Imidacloprid, moxidectin
Advocate 80 mg + 8 mg, kožni nanos, raztopina za velike mačke Imidakloprid, moksidektin
Advocate for extra-large dogs
Advocate za zelo velike pse
Advocate for extra-large dogs (> 25–40 kg)
Advocate za zelo velike pse (> 25-40 kg)
Advocate for extra-large dogs (> 25–40 kg)
Advocate za zelo velike pse. (> 25- 40 kg)
Advocate for extra-large dogs Pipette
Advocate za zelo velike pse Merilna kapalka
Advocate for large cats (> 4–8 kg)
Advocate za velike mačke ≥ 4–8 kg
Advocate for large cats Pipette
Advocate za velike mačke Merilna kapalka
Advocate for large dogs (> 10–25 kg)
Advocate za velike pse (> 10-25 kg)
Advocate for large dogs Pipette
Advocate za velike pse Merilna kapalka
Advocate for medium dogs (> 4–10 kg)
Advocate za srednje velike pse (> 4-10 kg)
Advocate for medium dogs Pipette
Advocate za srednje velike pse Merilna kapalka
Advocate for small cats ( 4 kg) and ferrets
Advocate za male mačke ≤ 4 kg in bele dihurje
Advocate for small cats and ferrets ( 4 kg)
Advocate za male mačke in bele dihurje (≤ 4 kg)
Advocate for small cats and ferrets Pipette
Advocate za male mačke in bele dihurje
Advocate for small dogs ( 4 kg)
Advocate za male pse. (≤ 4 kg)
Advocate for small dogs Pipette
Advocate za male pse Merilna kapalka
Advocate is applied to cats, ferrets and dogs from pre-filled pipettes.
Zdravilo se daje mačkam, belim dihurjem in psom iz napolnjenih merilnih kapalk.
Advocate is available as a spot-on solution and comes in different strengths and pack sizes, depending on whether it is for use on cats, on ferrets, or on dogs, and on the size of the animal being treated.
Zdravilo Advocate je na voljo kot raztopina za kožni nanos, in sicer v različnih jakostih in pakiranjih glede na to, ali je namenjeno za uporabo pri mačkah, belih dihurjih ali psih, ter glede na velikost zdravljene živali.
Advocate should be administered monthly for two consecutive months.
Zdravilo dajemo mesečno dva zaporedna meseca.
Advocate should not be used in kittens under 9 weeks of age or in puppies under 7 weeks of age.
Zdravilo Advocate se ne sme uporabljati pri mačkah, mlajših od devet tednov, ali psih, mlajših od sedmih tednov.
Advocate should not enter water courses as this may be dangerous for fish and other aquatic organisms.
Advocate ne sme priti v vodotoke, ker je lahko nevaren za ribe in druge vodne organizme.
Advocate Spot-on solution for Extra-Large
Advocate, raztopina za kožni nanos za zelo velike pse
Advocate Spot-on solution for Extra-Large Dogs
Advocate, raztopina za kožni nanos za zelo velike pse
Advocate Spot-on solution for Large Cats
Advocate, raztopina za kožni nanos za velike mačke
Advocate Spot-on solution for Large Dogs
Advocate, raztopina za kožni nanos za velike pse
Advocate Spot-on solution for Medium Dogs
Advocate, raztopina za kožni nanos za
Advocate Spot-on solution for Medium Dogs
Advocate, raztopina za kožni nanos za srednje velike pse
Advocate Spot-on solution for Small Cats and Ferrets
Advocate, raztopina za kožni nanos za male mačke in
Advocate Spot-on solution for Small Cats and Ferrets
Advocate, raztopina za kožni nanos za male mačke in bele dihurje
Advocate Spot-on solution for Small Dogs
Advocate, raztopina za kožni nanos za male pse
Adynamic bone disease may develop if PTH levels are chronically suppressed below approximately
Adinamična bolezen kosti se lahko pojavi, če je koncentracija PTH kronično zavrta pod približno
AE by body system
Neželeni učinki po organskih sistemih
AE by body system
Neželeni učinki, razvrščeni po organskih sistemih
AE, adverse event; NRT=Nicotine replacement therapy patch
AE  neželeni dogodek; NRT  nadomestno zdravljenje z nikotinskim obližem
aEach sachet contains 50 mg of REYATAZ
aEna vrečica vsebuje 50 mg zdravila REYATAZ
AED coadministered
Sočasno uporabljeni antiepileptiki
Aegerion Pharmaceuticals Ltd Tel: +80023437466
Aegerion Pharmaceuticals Ltd Tel: 80023437466
Aegerion Pharmaceuticals Ltd Τηλ: +80023437466
Aegerion Pharmaceuticals Ltd
Aerinaze
Zdravilo Aerinaze
Aerinaze is a blue and white oval bi-layer modified-release tablet with “D12” debossed in the blue layer.
Zdravilo Aerinaze je modro-bela ovalna dvoplastna tableta s podaljšanim sproščanjem z oznako “D12” na modri plasti tablete.
Aerinaze should also not be taken by people who have narrow- angle glaucoma (increased pressure inside the eye), urinary retention (difficulty in passing urine), heart or blood vessel diseases including hypertension (high blood pressure), hyperthyroidism (an overactive thyroid gland), or a history or risk of haemorrhagic stroke (stroke caused by bleeding within the brain).
Prav tako zdravila Aerinaze ne smejo jemati osebe, ki imajo glavkom ozkega zakotja (povečan tlak v notranjosti očesa), zastoj seča (težave pri izločanju seča), srčnožilne bolezni, vključno s hipertenzijo (visokim krvnim tlakom), hipertiroidizem (povečano delovanje ščitnice) ali anamnezo oziroma tveganje za hemoragično možgansko kap (kap zaradi krvavitve v možganih).
Aerinaze tablets contain a combination of two active ingredients, desloratadine which is an antihistamine and pseudoephedrine sulphate which is a decongestant.
Zdravilo Aerinaze vsebuje kombinacijo dveh zdravilnih učinkovin, desloratadin, ki je antihistaminik, in psevdoefedrinijev sulfat, ki je dekongestiv.
Aerius 5 mg film-coated tablets are packed in blisters in packs of 1, 2, 3, 5, 7, 10, 14, 15, 20, 21, 30,
5 mg filmsko obložene tablete Aerius so na voljo v pretisnih omotih po 1, 2, 3, 5, 7, 10, 14, 15, 20, 21,
Aerius contains desloratadine which is an antihistamine.
Zdravilo Aerius vsebuje desloratadin, ki je antihistaminik.
Aerius is indicated in adults and adolescents aged 12 years and older for the relief of symptoms associated with:
Zdravilo Aerius je indicirano pri odraslih in mladostnikih, starih 12 let in več, za lajšanje simptomov:
Aerius is indicated in adults, adolescents aged 12 years and older and children aged 6 – 11 years old for the relief of symptoms associated with:
Zdravilo Aerius je indicirano pri odraslih, mladostnikih, starih 12 let in več, in otrocih, starih 6 – 11 let, za lajšanje simptomov:
Aerius is indicated in adults, adolescents and children over the age of 1 year for the relief of symptoms associated with:
Zdravilo Aerius je indicirano pri odraslih, mladostnikih in otrocih, starejših od 1 leta, za lajšanje simptomov:
Aerius may be taken with or without a meal.
Zdravilo Aerius se lahko jemlje s hrano ali brez nje.
Aerius oral solution contains sorbitol
Zdravilo Aerius peroralna raztopina vsebuje sorbitol
Aerius oral solution contains sorbitol.
Aerius peroralna raztopina vsebuje sorbitol.
Aerius oral solution is also used to relieve the symptoms associated with urticaria (a skin condition caused by an allergy).
Zdravilo Aerius peroralna raztopina se uporablja tudi za lajšanje simptomov urtikarije (težave s kožo zaradi alergije).
Aerius oral solution is available in bottles of 30, 50, 60, 100, 120, 150, 225 and 300 ml, with a childproof cap.
Aerius peroralna raztopina je na voljo v stekleničkah po 30, 50, 60, 100, 120, 150, 225 in 300 ml, z zaporko, varno za otroke.
Aerius oral solution with food, drink and alcohol
Zdravilo Aerius peroralna raztopina skupaj s hrano, pijačo in alkoholom
Aerius orodispersible tablet contains aspartame
Zdravilo Aerius orodisperzibilna tableta vsebuje aspartam
Aerius orodispersible tablet does not need to be taken with water or liquid.
Zdravila Aerius orodisperzibilna tableta vam ni treba jemati z vodo ali tekočino.
Aerius orodispersible tablet is packed in unit dose blisters in packs of
Aerius orodisperzibilne tablete so na voljo v pretisnih omotih po
Aerius orodispersible tablet with food, drink and alcohol
Zdravilo Aerius orodisperzibilna tableta skupaj s hrano, pijačo in alkoholom
Aerius tablets effectively controlled symptoms for 24 hours.
Zdravilo Aerius učinkovito obvladuje te simptome za čas 24 ur.
Aerius tablets were effective in alleviating the burden of seasonal allergic rhinitis as shown by the total score of the rhino-conjunctivitis quality of life questionnaire.
Zdravilo Aerius je učinkovito ublažilo težave, povezane s sezonskim alergijskim rinitisom, kar je pokazal skupni rezultat vprašalnika o kakovosti življenja bolnikov z rinitisom in konjunktivitisom.
Aerius with food, drink and alcohol
Zdravilo Aerius skupaj s hrano, pijačo in alkoholom
Aerivio Spiromax 50 microgram/500 microgram inhalation powder
Aerivio Spiromax 50 mikrogramov/500 mikrogramov prašek za inhaliranje
Aerivio Spiromax 50 microgram/500 microgram inhalation powder
Airexar Spiromax 50 mikrogramov/500 mikrogramov prašek za inhaliranje
Aerivio Spiromax 50 microgram/500 microgram inhalation powder salmeterol/fluticasone propionate
Aerivio Spiromax 50 mikrogramov/500 mikrogramov prašek za inhaliranje salmeterol/flutikazonproprionat
Aerivio Spiromax 50 microgram/500 microgram inhalation powder salmeterol/fluticasone propionate
Airexar Spiromax 50 mikrogramov/500 mikrogramov prašek za inhaliranje salmeterol/flutikazonproprionat
Aerivio Spiromax 50 micrograms/500 micrograms Inhalation powder
Aerivio Spiromax 50 mikrogramov/500 mikrogramov prašek za inhaliranje
Aerivio Spiromax 50 micrograms/500 micrograms Inhalation powder
Airexar Spiromax 50 mikrogramov/500 mikrogramov prašek za inhaliranje
Aerivio Spiromax contains lactose
Zdravilo Aerivio Spiromax vsebuje laktozo
Aerivio Spiromax contains lactose
Zdravilo Airexar Spiromax vsebuje laktozo
Aerivio Spiromax contains salmeterol and fluticasone propionate, which have differing modes of action.
Zdravilo Aerivio Spiromax vsebuje salmeterol in flutikazonpropionat, ki imata različna načina delovanja.
Aerivio Spiromax contains salmeterol and fluticasone propionate, which have differing modes of action.
Zdravilo Airexar Spiromax vsebuje salmeterol in flutikazonpropionat, ki imata različna načina delovanja.
Aerivio Spiromax contains two medicines, salmeterol and fluticasone propionate:
Zdravilo Airexar Spiromax vsebuje dve učinkovini, salmeterol in flutikazonpropionat:
Aerivio Spiromax has no or negligible influence on the ability to drive and use machines.
Zdravilo Aerivio Spiromax nima vpliva ali ima zanemarljiv vpliv na sposobnost vožnje in upravljanja strojev.
Aerivio Spiromax has no or negligible influence on the ability to drive and use machines.
Zdravilo Airexar Spiromax nima vpliva ali ima zanemarljiv vpliv na sposobnost vožnje in upravljanja strojev.
Aerivio Spiromax helps to stop breathlessness and wheeziness coming on.
Zdravilo Airexar Spiromax pomaga preprečevati, da bi se zasoplost in piskajoče dihanje pojavila.
Aerivio Spiromax is a ‘hybrid medicine’.
Zdravilo Aerivio Spiromax je „hibridno zdravilo“.
Aerivio Spiromax is an inhalation powder.
Zdravilo Aerivio Spiromax je prašek za inhaliranje.
Aerivio Spiromax is an inhalation powder.
Zdravilo Airexar Spiromax je prašek za inhaliranje.
Aerivio Spiromax is for the treatment of patients with severe asthma only.
Zdravilo Airexar Spiromax je le za zdravljenje bolnikov s hudo astmo.
Aerivio Spiromax is for use in patients with severe asthma only.
Zdravilo Airexar Spiromax je namenjeno le za zdravljenje bolnikov s hudo astmo.
Aerivio Spiromax is indicated for use in adults aged 18 years and older only.
Zdravilo Aerivio Spiromax je indicirano samo pri odraslih, starih 18 let in več.
Aerivio Spiromax is indicated for use in adults aged 18 years and older only.
Zdravilo Airexar Spiromax je indicirano samo pri odraslih, starih 18 let in več.
Aerivio Spiromax is indicated in adults 18 years of age and older only.
Zdravilo Aerivio Spiromax je indicirano samo pri odraslih, starih 18 let ali več.
Aerivio Spiromax is indicated in adults 18 years of age and older only.
Zdravilo Airexar Spiromax je indicirano samo pri odraslih, starih 18 let ali več.
Aerivio Spiromax is not indicated for use in children and adolescents under the age of 18 years (see Section 4.2).
Zdravilo Airexar Spiromax ni namenjeno za uporabo pri otrocih in mladostnikih, mlajših od 18 let (glejte poglavje 4.2).
Aerivio Spiromax is not indicated for use in children, 12 years of age and younger or adolescents, 13 to 17 years of age.
Zdravilo Airexar Spiromax ni indicirano za uporabo pri otrocih, starih 12 let in manj, ali mladostnikih, starih, od 13 do 17 let.
Aerivio Spiromax is not intended as the treatment of asthma when a fixed-dose combination of salmeterol and fluticasone propionate is required for the first time.
Zdravilo Airexar Spiromax ni primerno za zdravljenje astme, če je fiksna kombinacija odmerka salmeterola in flutikazonpropionata potrebna prvič.
Aerivio Spiromax is not likely to affect your ability to drive or use machines.
Ni verjetno, da bi zdravilo Aerivio Spiromax vplivalo na vašo sposobnost vožnje ali upravljanja strojev.
Aerivio Spiromax is not likely to affect your ability to drive or use machines.
Ni verjetno, da bi zdravilo Airexar Spiromax vplivalo na vašo sposobnost vožnje ali upravljanja strojev.
Aerivio Spiromax is not recommended for use in children and adolescents aged less than 18 years.
Uporaba zdravila Airexar Spiromax ni priporočljiva pri otrocih in mladostnikih, mlajših od 18 let.
Aerivio Spiromax is not recommended for use in either children aged 12 years of age and younger or in adolescents aged 13 to 17 years.
Uporaba zdravila Airexar Spiromax ni priporočljiva pri otrocih, starih 12 let in manj, ali mladostnikih, starih, od 13 do 17 let.
Aerivio Spiromax is only appropriate for use in the treatment of patients with severe asthma.
Zdravilo Airexar Spiromax je primerno le za uporabo pri zdravljenju bolnikov s hudo astmo.
Aerivio Spiromax may affect the normal production of steroid hormones in the body, particularly if you have taken high doses for long periods of time.
Zdravilo Aerivio Spiromax lahko vpliva na normalno nastajanje steroidnih hormonov v telesu, zlasti če dalj časa jemljete visoke odmerke.
Aerivio Spiromax may affect the normal production of steroid hormones in the body, particularly if you have taken high doses for long periods of time.
Zdravilo Airexar Spiromax lahko vpliva na normalno nastajanje steroidnih hormonov v telesu, zlasti če dalj časa jemljete visoke odmerke.
Aerivio Spiromax may not be suitable to be taken with some other medicines.
Zdravilo Aerivio Spiromax morda ni primerno za sočasno jemanje z nekaterimi drugimi zdravili.
Aerivio Spiromax may not be suitable to be taken with some other medicines.
Zdravilo Airexar Spiromax morda ni primerno za sočasno jemanje z nekaterimi drugimi zdravili.
Aerivio Spiromax should be administered with caution in patients with active or quiescent pulmonary tuberculosis and fungal, viral or other infections of the airway.
Zdravilo Airexar Spiromax je treba uporabljati previdno pri bolnikih z aktivno ali mirujočo pljučno tuberkulozo ter pri glivičnih, virusnih ali drugih okužbah dihal.
Aerivio Spiromax should be discontinued immediately, the patient assessed and alternative therapy instituted if necessary.
Uporabo zdravila Airexar Spiromax je treba takoj prekiniti, bolnika pregledati in uvesti drugo zdravljenje, če je potrebno.
Aerivio Spiromax should be inhaled through the mouth into the lungs.
Zdravilo Aerivio Spiromax inhalirajte v pljuča skozi usta.
Aerivio Spiromax should be inhaled through the mouth into the lungs.
Zdravilo Airexar Spiromax inhalirajte v pljuča skozi usta.
Aerivio Spiromax should be used correctly in order to achieve effective treatment.
Zdravilo Airexar Spiromax je treba za učinkovito zdravljenje uporabljati pravilno.
Aerivio Spiromax should be used with caution in patients with severe cardiovascular disorders or heart rhythm abnormalities and in patients with diabetes mellitus, thyrotoxicosis, uncorrected hypokalaemia or patients predisposed to low levels of serum potassium.
Zdravilo Airexar Spiromax je treba zato uporabljati previdno pri bolnikih, ki imajo hude kardiovaskularne bolezni ali motnje srčnega ritma in pri bolnikih s sladkorno boleznijo, tirotoksikozo, nezdravljeno hipokaliemijo ali predispozicijo za nizke vrednosti serumskega kalija.
Aerivio Spiromax should only be used to treat severe asthma in adults aged 18 years and older and adults with COPD.
Zdravilo Aerivio Spiromax se lahko uporablja le za zdravljenje hude astme pri odraslih, starih 18 let in več, in pri odraslih s KOPB.
Aerivio Spiromax should only be used to treat severe asthma in adults aged 18 years and older and adults with COPD.
Zdravilo Airexar Spiromax se lahko uporablja le za zdravljenje hude astme pri odraslih, starih 18 let in več, in pri odraslih s KOPB.
AEs, considered by the investigator to be at least possibly drug-related and reported in at least two more patients treated with saxagliptin 5 mg compared to control, are described below by treatment regimen.
Spodaj so – po shemi zdravljenja – opisani neželeni učinki, za katere je raziskovalec ocenil, da so vsaj morda povezani z zdravilom, in so bili s 5 mg saksagliptina zabeleženi pri vsaj dveh bolnikih več kot med kontrolnimi.
Aesica Pharmaceuticals GmbH, Alfred-Nobel Strasse 10, D-40789 Monheim am Rhein, Germany .
Aesica Pharmaceuticals GmbH, Alfred-Nobel Strasse 10, D-40789 Monheim am Rhein, Nemčija.
Aesica Queenborough Limited Queenborough
Aesica Queenborough Limited North Road
Aesica Queenborough Limited, North Road, Queenborough, Kent, ME11 5EL, United Kingdom
Aesica Queenborough Limited, North Road, Queenborough, Kent, ME11 5EL, Velika Britanija